Novartis Ag (NVS) Treasury Shares (2009 - 2026)

Novartis Ag has disclosed Treasury Shares across 18 years of filings, most recently posting -$49.0 million for Q2 2026.

• In Q2 2026, Treasury Shares fell 48.48% year-over-year to -$49.0 million; the TTM figure through Jun 2026 stood at -$49.0 million (down 48.48% YoY), while the FY2025 annual figure was -$50.0 million, up 5.66% from the prior year.
• Treasury Shares came in at -$49.0 million for Q2 2026 at Novartis Ag, down from -$47.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of -$141.0 million in Q1 2020 to a low of -$5.5 billion in Q4 2019.
• Average Treasury Shares over 5 years is -$2.2 billion, with a median of -$2.5 billion recorded in 2022.
• Year-over-year, Treasury Shares surged 91.67% in 2022 and tumbled 229.27% in 2024.
• Over 5 years, Treasury Shares stood at $92.0 million in 2022, then plunged by 55.43% to $41.0 million in 2023, then plunged by 229.27% to -$53.0 million in 2024, then advanced by 5.66% to -$50.0 million in 2025, then advanced by 2.0% to -$49.0 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were -$49.0 million in Q2 2026, -$47.0 million in Q1 2026, and -$50.0 million in Q4 2025.